#GLP-1 agonists

[ follow ]
#glp-1-agonists
english.elpais.com
1 day ago
Wellness

What's the best way to lose weight, following a diet or taking drugs like Ozempic?

The importance of combating the social stigma around obesity and overweight while incorporating new drugs like GLP-1 agonists into comprehensive treatment plans. [ more ]
www.mercurynews.com
1 week ago
Medicine

High price of popular diabetes drugs deprives low-income people of effective treatment

Supply shortages and insurance hurdles for GLP-1 agonists due to high drug prices lead to affordability issues for patients with diabetes and obesity. [ more ]
english.elpais.com
1 week ago
Medicine

When Ozempic fails: Study sheds light on why some patients lose half as much weight as others

Genetic analysis can predict patient's response to semaglutide for weight loss, not effective for everyone. [ more ]
Inverse
2 weeks ago
Medicine

The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side Effects

GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects. [ more ]
www.scientificamerican.com
1 month ago
Wellness

New Weight-Loss Drugs Are Meant to Be Lifelong. What Happens When You Quit?

Weight-loss drugs like Wegovy and Ozempic are popular but many users quit due to factors like cost, side effects, and limited coverage. [ more ]
Nature
1 month ago
Wellness

Obesity drugs aren't always forever. What happens when you quit?

GLP-1 agonists are popular weight-loss drugs, but many people discontinue due to cost, side effects, and other factors. Stopping these medications can lead to weight regain. [ more ]
moreglp-1-agonists
Axios
6 months ago
Health

Doctors grapple with patients' demand for weight-loss drugs

Primary care doctors are facing an influx of requests for anti-obesity drugs, including from patients who may not necessarily need them.
The demand for GLP-1 agonist drugs, such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound, is expected to increase after new data shows their potential in reducing heart problems.
There is a need for balanced consideration of other treatments and interventions before resorting to these drugs, as not everyone may require them. [ more ]
[ Load more ]